HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Trépo Selected Research

Infections

10/2008A French prospective observational study of the treatment of chronic hepatitis C in drug abusers.
8/2007Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
4/2006Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides.
12/2005Clinical impact of occult HBV infections.
11/2004Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
11/2004Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
4/2004[Hepatitis G virus and labile blood products: role of transfusional transmission].
12/2001Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro.
11/2001Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease.
5/2001Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Trépo Research Topics

Disease

16Infections
10/2008 - 01/2000
10Chronic Hepatitis B
08/2009 - 02/2000
7Hepatocellular Carcinoma (Hepatoma)
12/2005 - 01/2000
6Chronic Hepatitis C
08/2007 - 05/2000
5Viremia
11/2004 - 01/2000
4Hepatitis B
01/2009 - 04/2000
4Fibrosis (Cirrhosis)
08/2007 - 01/2000
3Hepatitis C
06/2009 - 05/2001
3Liver Diseases (Liver Disease)
04/2008 - 11/2001
2Coinfection
08/2007 - 11/2001
2Hepatitis
12/2005 - 03/2001
2Neoplasms (Cancer)
11/2001 - 08/2000
1Acute Retroviral Syndrome
07/2008
1Hepatolenticular Degeneration (Wilson's Disease)
04/2008
1Liver Failure
04/2008
1Acute Liver Failure (Fulminant Hepatic Failure)
04/2008
1Alcoholic Hepatitis
12/2005
1Arthralgia (Joint Pain)
08/2005
1Reinfection
11/2001
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
11/2001
1Polyarteritis Nodosa (Periarteritis Nodosa)
05/2001
1Chronic Hepatitis (Chronic Active Hepatitis)
04/2001
1Virus Diseases (Viral Diseases)
02/2001
1Schistosomiasis (Bilharziasis)
01/2001
1Peritonitis
08/2000
1Cholestasis
06/2000
1Sarcoma (Soft Tissue Sarcoma)
01/2000
1Hemangiosarcoma (Angiosarcoma)
01/2000
1Cholangiocarcinoma
01/2000
1Inflammation (Inflammations)
01/2000

Drug/Important Bio-Agent (IBA)

10Antiviral Agents (Antivirals)IBA
08/2009 - 01/2000
6DNA (Deoxyribonucleic Acid)IBA
08/2007 - 01/2000
6Interferon-alpha (Interferon Alfa)IBA
05/2001 - 06/2000
5InterferonsIBA
08/2005 - 05/2000
4NucleosidesIBA
04/2001 - 02/2000
3Ribavirin (Virazole)FDA LinkGeneric
06/2009 - 12/2000
3Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2007 - 11/2001
3Lamivudine (Epivir)FDA Link
04/2001 - 11/2000
2Transaminases (Aminotransferases)IBA
01/2009 - 01/2001
2Viral RNAIBA
07/2008 - 04/2004
2RNA (Ribonucleic Acid)IBA
07/2008 - 08/2007
2Peptides (Polypeptides)IBA
04/2006 - 01/2001
2Proteins (Proteins, Gene)FDA Link
04/2006 - 11/2004
2VaccinesIBA
04/2006 - 01/2001
2Hepatitis B e AntigensIBA
01/2004 - 09/2000
2dexelvucitabineIBA
04/2001 - 01/2000
2Famciclovir (Famvir)FDA LinkGeneric
06/2000 - 04/2000
2Codon (Codons)IBA
01/2000 - 01/2000
1Buprenorphine (Subutex)FDA LinkGeneric
10/2008
1CopperIBA
04/2008
1EpitopesIBA
04/2006
1Rheumatoid FactorIBA
08/2005
1CryoglobulinsIBA
08/2005
1Complement System Proteins (Complement)IBA
08/2005
1Antinuclear AntibodiesIBA
08/2005
1Methotrexate (Mexate)FDA LinkGeneric
08/2005
1Interferon-gamma (Interferon, gamma)IBA
11/2004
1AntibodiesIBA
04/2004
1Hepatitis B virus P proteinIBA
01/2004
1adefovir dipivoxil (Hepsera)FDA Link
01/2004
1Lipoproteins (Lipoprotein)IBA
12/2001
1Hepatitis B Core AntigensIBA
11/2001
1Surface Antigens (Surface Antigen)IBA
11/2001
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2001
1Biomarkers (Surrogate Marker)IBA
01/2001
1Interferon beta-1aFDA Link
12/2000
1Interferon-betaIBA
12/2000
1AgarIBA
08/2000
1Bile Acids and Salts (Bile Acids)IBA
06/2000
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
06/2000
1Arginine (L-Arginine)FDA Link
01/2000
1Serine (L-Serine)FDA Link
01/2000
1Thorium Dioxide (Thorotrast)IBA
01/2000
1Vinyl Chloride (Chloroethylene)IBA
01/2000
1vinyl fluoride (fluoroethylene)IBA
01/2000
1Viral AntigensIBA
01/2000
1Viral DNAIBA
01/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2000

Therapy/Procedure

12Therapeutics
08/2009 - 02/2000
3Highly Active Antiretroviral Therapy (HAART)
07/2008 - 08/2000
3Transplantation
04/2008 - 03/2001
1Liver Transplantation
04/2008
1Drug Therapy (Chemotherapy)
11/2001
1Plasma Exchange
05/2001
1Peritoneal Dialysis
08/2000